These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 19008265)

  • 21. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Hawrelak JA; Wohlmuth H; Pattinson M; Myers SP; Goldenberg JZ; Harnett J; Cooley K; Van De Venter C; Reid R; Whitten DL
    Complement Ther Med; 2020 Jan; 48():102233. PubMed ID: 31987249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chinese herbal medicine versus antispasmodics in the treatment of irritable bowel syndrome: A network meta-analysis.
    Chen M; Qin D; Huang SL; Tang TC; Zheng H
    Neurogastroenterol Motil; 2021 Aug; 33(8):e14107. PubMed ID: 33660903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peppermint oil.
    Kligler B; Chaudhary S
    Am Fam Physician; 2007 Apr; 75(7):1027-30. PubMed ID: 17427617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of antispasmodics in the treatment of irritable bowel syndrome.
    Annaházi A; Róka R; Rosztóczy A; Wittmann T
    World J Gastroenterol; 2014 May; 20(20):6031-43. PubMed ID: 24876726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis.
    Bosman M; Elsenbruch S; Corsetti M; Tack J; Simrén M; Winkens B; Boumans T; Masclee A; Keszthelyi D
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):459-473. PubMed ID: 33765447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis: The treatment of irritable bowel syndrome.
    Lesbros-Pantoflickova D; Michetti P; Fried M; Beglinger C; Blum AL
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1253-69. PubMed ID: 15606387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children.
    Kline RM; Kline JJ; Di Palma J ; Barbero GJ
    J Pediatr; 2001 Jan; 138(1):125-8. PubMed ID: 11148527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acupuncture vs. antispasmodics in the treatment of irritable bowel syndrome: An adjusted indirect treatment comparison meta-analysis.
    Shi YZ; Tao QF; Qin D; Chen M; Yu SG; Zheng H
    Front Physiol; 2022; 13():1001978. PubMed ID: 36277191
    [No Abstract]   [Full Text] [Related]  

  • 30. Complementary and alternative medicine for treatment of irritable bowel syndrome.
    Shen YH; Nahas R
    Can Fam Physician; 2009 Feb; 55(2):143-8. PubMed ID: 19221071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis.
    Qin D; Tao QF; Huang SL; Chen M; Zheng H
    Front Pharmacol; 2022; 13():757969. PubMed ID: 35281934
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
    Chapman ND; Grillage MG; Mazumder R; Atkinson SN
    Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome.
    Ford AC; Moayyedi P
    Aliment Pharmacol Ther; 2010 Jul; 32(2):144-58. PubMed ID: 20412064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
    Evans BW; Clark WK; Moore DJ; Whorwell PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis.
    Pittler MH; Ernst E
    Am J Gastroenterol; 1998 Jul; 93(7):1131-5. PubMed ID: 9672344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of irritable bowel syndrome in primary care.
    Jones R
    BMJ; 2008 Nov; 337():a2213. PubMed ID: 19008267
    [No Abstract]   [Full Text] [Related]  

  • 37. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial.
    Bijkerk CJ; de Wit NJ; Muris JW; Whorwell PJ; Knottnerus JA; Hoes AW
    BMJ; 2009 Aug; 339():b3154. PubMed ID: 19713235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antispasmodics for labour.
    Rohwer AC; Khondowe O; Young T
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009243. PubMed ID: 22895986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypnotherapy for treatment of irritable bowel syndrome.
    Webb AN; Kukuruzovic RH; Catto-Smith AG; Sawyer SM
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005110. PubMed ID: 17943840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Guidelines for the treatment of irritable bowel syndrome].
    Kwon JG; Park KS; Park JH; Park JM; Park CH; Lee KJ; Park HJ; Rhee JC;
    Korean J Gastroenterol; 2011 Feb; 57(2):82-99. PubMed ID: 21350320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.